Bellwether Bio
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology, Healthcare, Diagnostics
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Bellwether Bio
UW Spinout Bellwether Bio Raises $2.7M Seed to Commercialize Non‑Invasive Liquid Biopsy Founded by Jay Shendure and Matthew Snyder
Bellwether Bio, a University of Washington spinout founded by genomics researcher Jay Shendure and technologist Matthew Snyder, is commercializing a non-invasive liquid biopsy that analyzes tumor DNA in blood and raised an oversubscribed seed round totaling $2.7 million per an SEC filing. Investors include the UW’s W Fund, WRF Capital and Bioeconomy Capital, and the company says it is collaborating with cancer diagnostics firms to validate and commercialize the technology.
Questions about Bellwether Bio
What is Bellwether Bio?
Seattle, WA, US
Who invested in Bellwether Bio, and how much has it raised?
Members of Seattle Flow see Bellwether Bio's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Bellwether Bio based?
Bellwether Bio is headquartered in Seattle, WA, US.